DK3606926T3 - Heteroaromatiske forbindelser anvendelige i terapi - Google Patents
Heteroaromatiske forbindelser anvendelige i terapi Download PDFInfo
- Publication number
- DK3606926T3 DK3606926T3 DK18716212.8T DK18716212T DK3606926T3 DK 3606926 T3 DK3606926 T3 DK 3606926T3 DK 18716212 T DK18716212 T DK 18716212T DK 3606926 T3 DK3606926 T3 DK 3606926T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapy
- heteroaromatic compounds
- compounds use
- heteroaromatic
- compounds
- Prior art date
Links
- 150000002390 heteroarenes Chemical class 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17165082 | 2017-04-05 | ||
| PCT/EP2018/058522 WO2018185120A1 (en) | 2017-04-05 | 2018-04-04 | Heteroaromatic compounds useful in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3606926T3 true DK3606926T3 (da) | 2021-07-05 |
Family
ID=58489645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18716212.8T DK3606926T3 (da) | 2017-04-05 | 2018-04-04 | Heteroaromatiske forbindelser anvendelige i terapi |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11001587B2 (da) |
| EP (1) | EP3606926B1 (da) |
| JP (1) | JP7200126B2 (da) |
| CN (1) | CN110520424B (da) |
| AU (1) | AU2018248581B2 (da) |
| CA (1) | CA3057408A1 (da) |
| DK (1) | DK3606926T3 (da) |
| ES (1) | ES2880327T3 (da) |
| PL (1) | PL3606926T3 (da) |
| RU (1) | RU2770363C2 (da) |
| WO (1) | WO2018185120A1 (da) |
| ZA (1) | ZA201907303B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3419980B1 (en) | 2016-02-26 | 2025-01-01 | The Board of Trustees of the Leland Stanford Junior University | Pi-kinase inhibitors with anti-infective activity |
| CN110520424B (zh) * | 2017-04-05 | 2022-06-21 | 库洛维公司 | 用于疗法的杂芳族化合物 |
| KR102821765B1 (ko) | 2018-10-10 | 2025-06-16 | 큐로비르 아베 | 바이러스 감염을 치료하기 위한, 2,6-다이메틸-N-((피리딘-4-일)메틸)이미다졸[1,2-b]피리다진-8-아민 및 2,5-다이메틸-N-[(피리딘-4-일)메틸]피라졸로[1,5-a]피리미딘-7-아민 유도체 |
| WO2020074160A1 (en) | 2018-10-10 | 2020-04-16 | Curovir Ab | Condensed pyrimidine or pyridazine derivatives as antiviral agents |
| CA3126143A1 (en) * | 2019-01-11 | 2020-07-16 | The Board Of Trustees Of The Leland Stanford Junior University | Pi4-kinase inhibitors with anti-cancer activity |
| EP3941909A4 (en) | 2019-03-21 | 2023-01-25 | The Board Of Trustees Of The Leland Stanford Junior University | Pi4-kinase inhibitors and methods of using the same |
| WO2021032611A1 (en) | 2019-08-20 | 2021-02-25 | Curovir Ab | Heteroaromatic compounds useful in therapy |
| EP4676485A1 (en) | 2023-03-09 | 2026-01-14 | Curovir Ab | Compound and formulation for systemic therapy by oral transmucosal administration |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| US6191131B1 (en) * | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
| CN1377354A (zh) * | 1999-09-30 | 2002-10-30 | 纽罗杰有限公司 | 某些亚烷基二胺一取代的吡唑并[1,5－a]－1,5－嘧啶和吡唑并[1,5－a]－1,3,5－三嗪 |
| RU2340611C2 (ru) * | 2000-09-15 | 2008-12-10 | Вертекс Фармасьютикалз Инкорпорейтед | Производные пиразола, используемые в качестве ингибиторов протеинкиназы |
| US20070078136A1 (en) | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| WO2010086040A1 (en) | 2009-01-29 | 2010-08-05 | Biomarin Iga, Ltd. | Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy |
| FR2943058B1 (fr) | 2009-03-11 | 2011-06-03 | Centre Nat Rech Scient | Derives de pyrazolo°1,5-a!-1,3,5-triazines, leur preparation et leur application en therapeutique. |
| AP4075A (en) | 2011-05-04 | 2017-03-23 | Rhizen Pharmaceuticals S A | Novel compounds as modulators of protein kinases |
| EP2634189A1 (en) | 2012-03-01 | 2013-09-04 | Lead Discovery Center GmbH | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
| ES2954126T3 (es) | 2014-01-22 | 2023-11-20 | Curovir Ab | Derivados del pirazolo[1,5-a]pirimidina-7-amina útiles en terapia |
| DE112015001328B4 (de) * | 2014-03-18 | 2020-06-04 | Micromass Uk Limited | Matrixunterstützte Flüssigextraktions-Laserdesorptionsionisations-Ionenquelle |
| CA2989722C (en) | 2015-06-24 | 2023-09-19 | Jacob Westman | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy |
| CN110520424B (zh) * | 2017-04-05 | 2022-06-21 | 库洛维公司 | 用于疗法的杂芳族化合物 |
-
2018
- 2018-04-04 CN CN201880023679.2A patent/CN110520424B/zh active Active
- 2018-04-04 ES ES18716212T patent/ES2880327T3/es active Active
- 2018-04-04 WO PCT/EP2018/058522 patent/WO2018185120A1/en not_active Ceased
- 2018-04-04 EP EP18716212.8A patent/EP3606926B1/en active Active
- 2018-04-04 AU AU2018248581A patent/AU2018248581B2/en active Active
- 2018-04-04 RU RU2019133777A patent/RU2770363C2/ru not_active Application Discontinuation
- 2018-04-04 JP JP2019554725A patent/JP7200126B2/ja active Active
- 2018-04-04 US US16/495,903 patent/US11001587B2/en active Active
- 2018-04-04 CA CA3057408A patent/CA3057408A1/en active Pending
- 2018-04-04 PL PL18716212T patent/PL3606926T3/pl unknown
- 2018-04-04 DK DK18716212.8T patent/DK3606926T3/da active
-
2019
- 2019-11-04 ZA ZA2019/07303A patent/ZA201907303B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201907303B (en) | 2022-07-27 |
| AU2018248581B2 (en) | 2022-05-26 |
| RU2019133777A (ru) | 2021-04-23 |
| EP3606926A1 (en) | 2020-02-12 |
| WO2018185120A1 (en) | 2018-10-11 |
| PL3606926T3 (pl) | 2021-11-02 |
| CA3057408A1 (en) | 2018-10-11 |
| CN110520424A (zh) | 2019-11-29 |
| JP7200126B2 (ja) | 2023-01-06 |
| US20200031833A1 (en) | 2020-01-30 |
| BR112019019796A2 (pt) | 2020-04-22 |
| EP3606926B1 (en) | 2021-05-26 |
| RU2770363C2 (ru) | 2022-04-15 |
| RU2019133777A3 (da) | 2021-04-23 |
| JP2020516599A (ja) | 2020-06-11 |
| AU2018248581A1 (en) | 2019-11-07 |
| US11001587B2 (en) | 2021-05-11 |
| CN110520424B (zh) | 2022-06-21 |
| ES2880327T3 (es) | 2021-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272232A (en) | Glp-1 compositions and uses thereof | |
| EP3463464A4 (en) | ASSOCIATION TREATMENT | |
| EP3551285C0 (en) | DEFIBRILLATOR | |
| DE112017004654A5 (de) | Applikator | |
| EP3291824A4 (en) | ANTIMICROBIAL THERAPY | |
| DK3474802T3 (da) | Medicinsk forbinding | |
| DK3590543T3 (da) | Medicinsk forbinding | |
| EP3340833C0 (en) | PHOTO-ACTIVABILABLE FORMULATION APPLICATOR WITH CONNECTION | |
| EP3245009C0 (en) | ANTISEPTIC APPLICATOR | |
| DK3606926T3 (da) | Heteroaromatiske forbindelser anvendelige i terapi | |
| DK3373874T3 (da) | Medicinsk forbinding | |
| FR3036260B1 (fr) | Applicateur cosmetique | |
| DK4119569T3 (da) | Konjugerede antisense-forbindelser til anvendelse i behandling | |
| HRP20181490T1 (hr) | Spojevi 1, 3, 4-tiadiazola i njihova upotreba u liječenju raka | |
| DK3710000T3 (da) | Tradipitant til anvendelse til behandling af gastroparese | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| FR3036594B1 (fr) | Applicateur cosmetique | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| EP3413927A4 (en) | CANCER THERAPY | |
| DK3408265T3 (da) | Terapeutiske forbindelser | |
| EP3345648A4 (en) | APPLICATOR | |
| EP3512553A4 (en) | KLRG1 EXHAUST THERAPY | |
| IL262851A (en) | Combination prime: boost therapy | |
| EP3541931A4 (en) | COMBINED FRACTAL TREATMENT | |
| DK3393478T3 (da) | Kombinationsterapi |